Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of oxaliplatin in treating patients who
have advanced cancer plus liver dysfunction.